The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
PDF) Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Living With - HealthTree for Multiple Myeloma
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Kappa free light chains.. can anyone explain this to me. : r/multiplemyeloma
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar